Trials / Completed
CompletedNCT01962584
CMR in Patients With Myocarditis
Value of CMR Including T1 Mapping in Patients With Acute Myocarditis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 66 (actual)
- Sponsor
- University Hospital, Bonn · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the additive values of T1 mapping in patients with acute myocarditis.
Detailed description
Cardiac magnetic resonance (CMR) is an established non-invasive diagnostic tool for acute and chronic myocarditis. Established CMR criteria for diagnosing myocarditis are edema on black-blood T2-weighted imaging, relative contrast enhancement seen on T1-weighted imaging for assessment of hyperemia, and late contrast-agent enhancement seen with inversion recovery late enhancement technique for visualization of myocardial fibrosis. Recently, tissue characterization based on calculation of myocardial T1 relaxation time (T1 mapping) as well as T1-derived extracellular volume fraction has become available. Recently, reference values for myocardial T1 relaxation times at 3T for healthy volunteers were published for CMR. However, to date no comprehensive data for multiparametric CMR in patients with suspected myocarditis at 3 Tesla is available. Therefore, the purpose of this prospective study was to evaluate the diagnostic value of CMR at 3T in patients with suspected acute myocarditis using a multiparametric CMR approach including T1 mapping as novel tool for tissue characterization. CMR will be performed within 7 days after hospital admission for "suspected acute myocarditis".
Conditions
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2014-10-01
- Completion
- 2014-10-01
- First posted
- 2013-10-14
- Last updated
- 2015-12-11
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01962584. Inclusion in this directory is not an endorsement.